331 related articles for article (PubMed ID: 30221419)
21. MAD ointment ameliorates Imiquimod-induced psoriasiform dermatitis by inhibiting the IL-23/IL-17 axis in mice.
OuYang Q; Pan Y; Luo H; Xuan C; Liu J; Liu J
Int Immunopharmacol; 2016 Oct; 39():369-376. PubMed ID: 27540765
[TBL] [Abstract][Full Text] [Related]
22. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
[TBL] [Abstract][Full Text] [Related]
23. 3, 3'- diindolylmethane hinders IL-17A/IL-17RA interaction and mitigates imiquimod-induced psoriasiform in mice.
Srikanth M; Rasool M
Int Immunopharmacol; 2022 Aug; 109():108795. PubMed ID: 35487087
[TBL] [Abstract][Full Text] [Related]
24. Antrodia cinnamomea Extract Inhibits Th17 Cell Differentiation and Ameliorates Imiquimod-Induced Psoriasiform Skin Inflammation.
Li MH; Wu HC; Yao HJ; Lin CC; Wen SF; Pan IH
Am J Chin Med; 2015; 43(7):1401-17. PubMed ID: 26477794
[TBL] [Abstract][Full Text] [Related]
25. Tranexamic acid improves psoriasis-like skin inflammation: Evidence from in vivo and in vitro studies.
Hseu JH; Chan CI; Vadivalagan C; Chen SJ; Yen HR; Hseu YC; Yang HL; Wu PY
Biomed Pharmacother; 2023 Oct; 166():115307. PubMed ID: 37573659
[TBL] [Abstract][Full Text] [Related]
26. Ethanol extract of Herpetospermum caudigerum Wall ameliorates psoriasis-like skin inflammation and promotes degradation of keratinocyte-derived ICAM-1 and CXCL9.
Zhong Y; Zhang BW; Li JT; Zeng X; Pei JX; Zhang YM; Yang YX; Li FL; Deng Y; Zhao Q
J Integr Med; 2023 Nov; 21(6):584-592. PubMed ID: 37989697
[TBL] [Abstract][Full Text] [Related]
27. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production.
Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ
Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108
[TBL] [Abstract][Full Text] [Related]
28. Hydroxychloroquine exacerbates imiquimod-induced psoriasis-like dermatitis through stimulating overexpression of IL-6 in keratinocytes.
Yen LJ; Chen YC; Wang KC; Shih MC; Li CL; Yu SJ; Lu LY
Immunopharmacol Immunotoxicol; 2024 Feb; 46(1):128-137. PubMed ID: 38059657
[TBL] [Abstract][Full Text] [Related]
29. Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice.
Sun J; Zhao Y; Hu J
PLoS One; 2013; 8(6):e67078. PubMed ID: 23825622
[TBL] [Abstract][Full Text] [Related]
30. Imiquimod-applied Interleukin-10 deficient mice better reflects severe and persistent psoriasis with systemic inflammatory state.
Jin SP; Koh SJ; Yu DA; Kim MW; Yun HT; Lee DH; Yoon HS; Cho S; Park HS
Exp Dermatol; 2018 Jan; 27(1):43-49. PubMed ID: 28677206
[TBL] [Abstract][Full Text] [Related]
31. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.
van der Fits L; Mourits S; Voerman JS; Kant M; Boon L; Laman JD; Cornelissen F; Mus AM; Florencia E; Prens EP; Lubberts E
J Immunol; 2009 May; 182(9):5836-45. PubMed ID: 19380832
[TBL] [Abstract][Full Text] [Related]
32. Topical histone deacetylase 1 inhibitor Entinostat ameliorates psoriasiform dermatitis through suppression of IL-17A response.
Jiang Y; Lu S; Lai Y; Wang L
J Dermatol Sci; 2023 Jun; 110(3):89-98. PubMed ID: 37173222
[TBL] [Abstract][Full Text] [Related]
33. Protectin D1 reduces imiquimod-induced psoriasiform skin inflammation.
Park KD; Kim N; Kang J; Dhakal H; Kim JY; Jang YH; Lee WJ; Lee SJ; Kim SH
Int Immunopharmacol; 2021 Sep; 98():107883. PubMed ID: 34153674
[TBL] [Abstract][Full Text] [Related]
34. Dual targeting of mTOR/IL-17A and autophagy by fisetin alleviates psoriasis-like skin inflammation.
Roy T; Banang-Mbeumi S; Boateng ST; Ruiz EM; Chamcheu RN; Kang L; King JA; Walker AL; Nagalo BM; Kousoulas KG; Esnault S; Huang S; Chamcheu JC
Front Immunol; 2022; 13():1075804. PubMed ID: 36741386
[TBL] [Abstract][Full Text] [Related]
35. Cudraxanthone D Ameliorates Psoriasis-like Skin Inflammation in an Imiquimod-Induced Mouse Model via Inhibiting the Inflammatory Signaling Pathways.
Kim N; Lee S; Kang J; Choi YA; Jang YH; Jeong GS; Kim SH
Molecules; 2021 Oct; 26(19):. PubMed ID: 34641629
[TBL] [Abstract][Full Text] [Related]
36. Liangxue Jiedu formula improves imiquimod-induced psoriasiform dermatitis with circadian desynchrony by regulating Th17 cell differentiation based on network pharmacological analysis.
Xie X; Zhang L; Lin Y; Liu X; Han X; Li P
J Ethnopharmacol; 2023 Dec; 317():116807. PubMed ID: 37331449
[TBL] [Abstract][Full Text] [Related]
37. Ferulic acid altered IL-17A/IL-17RA interaction and protected against imiquimod-induced psoriasis-like skin injury in mice.
Lo HY; Li CC; Cheng HM; Liu IC; Ho TY; Hsiang CY
Food Chem Toxicol; 2019 Jul; 129():365-375. PubMed ID: 31054998
[TBL] [Abstract][Full Text] [Related]
38. NETs contribute to psoriasiform skin inflammation: A novel therapeutic approach targeting IL-36 cytokines by a small molecule tetrahydroxystilbene glucoside.
Zhan ZY; Jiang M; Zhang ZH; An YM; Wang XY; Wu YL; Nan JX; Lian LH
Phytomedicine; 2024 Aug; 131():155783. PubMed ID: 38838402
[TBL] [Abstract][Full Text] [Related]
39. Ginsenoside compound K ameliorates imiquimod-induced psoriasis-like dermatitis through inhibiting REG3A/RegIIIγ expression in keratinocytes.
Fan H; Wang Y; Zhang X; Chen J; Zhou Q; Yu Z; Chen Y; Chen Z; Gu J; Shi Y
Biochem Biophys Res Commun; 2019 Aug; 515(4):665-671. PubMed ID: 31182284
[TBL] [Abstract][Full Text] [Related]
40. Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model.
Liu C; Liu H; Lu C; Deng J; Yan Y; Chen H; Wang Y; Liang CL; Wei J; Han L; Dai Z
Clin Exp Immunol; 2019 Dec; 198(3):403-415. PubMed ID: 31407330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]